NINJ1

Chr 9

ninjurin 1

Also known as: NIN1, NINJURIN, hNINJ1

The ninjurin protein mediates plasma membrane rupture during programmed cell death pathways including pyroptosis and necroptosis, and functions as a homophilic adhesion molecule that promotes neurite outgrowth and nerve regeneration. Gain-of-function mutations in NINJ1 cause a dominant neuroinflammatory disorder characterized by recurrent episodes of sterile inflammation affecting the nervous system. The pathogenic mechanism involves excessive plasma membrane rupture leading to release of damage-associated molecular patterns that propagate inflammatory responses.

OMIMResearchSummary from RefSeq, UniProt, Mechanism
MultiplemechanismLOEUF 1.18
Clinical SummaryNINJ1
Population Constraint (gnomAD)
Low constraint (pLI 0.12) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
29 unique Pathogenic / Likely Pathogenic· 23 VUS of 57 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.18LOEUF
pLI 0.117
Z-score 1.32
OE 0.38 (0.151.18)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
1.01Z-score
OE missense 0.71 (0.580.87)
69 obs / 97.0 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.38 (0.151.18)
00.351.4
Missense OE0.71 (0.580.87)
00.61.4
Synonymous OE0.93
01.21.6
LoF obs/exp: 2 / 5.3Missense obs/exp: 69 / 97.0Syn Z: 0.39
DN
0.77top 25%
GOF
0.78top 25%
LOF
0.2484th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

57 submitted variants in ClinVar

Classification Summary

Pathogenic26
Likely Pathogenic3
VUS23
26
Pathogenic
3
Likely Pathogenic
23
VUS

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
26
0
26
Likely Pathogenic
0
0
3
0
3
VUS
0
20
3
0
23
Likely Benign
0
0
0
0
0
Benign
0
0
0
0
0
Total02032052

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

NINJ1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Full-Text Mentions
NLP-detected gene mentions in article bodies · via PubTator3
PubTator3
Top 5 full-text resultsSearch PubTator3 ↗